Navigation Links
Lipitor Lawsuits Continue to Be Filed in South Carolina Litigation, Bernstein Liebhard LLP Reports
Date:7/20/2014

(PRWEB) July 20, 2014

Lipitor lawsuits (http://www.thelipitorlawsuit.com/) alleging similar injuries caused by the cholesterol-lowering statin are being filed by the dozens in a federal multidistrict litigation underway in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports.

According to documents published on July 15th, a total of 959 claims are now pending in the federal proceeding, which was established for Lipitor claims that similarly allege new-onset Type 2 diabetes caused by the cholesterol medication. Plaintiffs in these cases accuse Pfizer, Inc. of failing to adequately warn about this side effect in its marketing of Lipitor. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

“On a regular basis, our Firm hears from individuals who allegedly developed Type 2 diabetes after taking Lipitor. We are pleased to see this litigation continuing to move forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to individuals who may have sustained injuries caused by Lipitor.

Lipitor Lawsuits
Court records indicate that concerns about the alleged association between Lipitor and diabetes have grown steadily since February 2012, when the U.S. Food and Drug Administration (FDA) warned that all statin manufacturers, including Pfizer, update their product labeling to include information about the risk for this disease. Preceding the FDA alert were the findings of a January 2012 study in JAMA: Internal Medicine that women taking Lipitor or another stain may run an increased risk for Type 2 diabetes.*

Lipitor lawsuits now filed in South Carolina federal court allege that Pfizer’s adjusted Lipitor labeling in February 2012 did not suffice, and that patients were still not properly warned about its potential to cause diabetes. They also accuse the company of knowing about this risk prior to February 2012, and withholding it from the public to protect market share.

Alleged victims of Lipitor and diabetes may be entitled to compensation from Pfizer, Inc. for their injury-related damages. To learn more about the possible association between Lipitor and diabetes, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to obtain a free legal review.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993? As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.thelipitorlawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12030612.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
2. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
3. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
4. Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
5. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
6. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
7. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
8. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
9. Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
10. Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
11. Dozens of Lipitor Lawsuits Involving Diabetes Allegations Moved to Federal Court, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... 2017 , ... Science-based sleep company Level Sleep ... HCI students, faculty, and alumni can acquire Level Sleep’s unique sleep system in ... community to receive educational content on sleep and proper biomechanics that will empower ...
(Date:2/28/2017)... ... ... BrightStar Care Marietta announced that it has received the 2017 Best of Home ... only to top-ranking home care providers, based on client satisfaction scores gathered by Home ... from across the country who have proven their ability to provide the highest quality ...
(Date:2/27/2017)... ... February 27, 2017 , ... Hotze Health & Wellness Center ... as its New Guest Director. , Brandl is a dynamic and influential ... He began his professional career at Omnium Worldwide, now known as West Corporation, ...
(Date:2/27/2017)... ... 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working as ... Now, she writes about God, when she isn’t swimming as a performing mermaid. , Her ... BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... 2014. The company had 800 customers and 2,250 RCEs at the time of ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Inc. (Nasdaq: IONS ) today reported that ... pro forma operating income of $25.8 million and $665.2 ... Company also reported a GAAP loss from operations of ... significant accomplishments for Ionis, culminating in the U.S. approval ... broad label. The approval of SPINRAZA is a testament ...
(Date:2/28/2017)... ... Research and Markets has announced the addition of ... report to their offering. The global active pharmaceutical ... 239.8 billion by 2025. The rising prevalence of lifestyle-induced & age-related ... forecast period. Advancements in recombinant molecular technologies and high capitalization for ...
(Date:2/28/2017)... SAN FRANCISCO, Calif. , Feb. 28, 2017 ... today announced that it will report its fourth ... close on Tuesday, March 7, 2017.  Rigel senior ... conference call and webcast at 5:00pm Eastern Time ... Participants can access the live conference ...
Breaking Medicine Technology: